Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huisman, C.
Right arrow Articles by Giaccone, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huisman, C.
Right arrow Articles by Giaccone, G.
Clinical Cancer Research Vol. 8, 596-606, February 2002
© 2002 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Paclitaxel Triggers Cell Death Primarily via Caspase-independent Routes in the Non-Small Cell Lung Cancer Cell Line NCI-H4601

Cynthia Huisman2, Carlos G. Ferreira2, Linda E. Bröker, Jose A. Rodriguez, Egbert F. Smit, Pieter E. Postmus, Frank A. E. Kruyt and Giuseppe Giaccone3

Departments of Medical Oncology [C. H., C. G. F., L. E. B., J. A. R., F. A. E. K., G. G.] and Pulmonary Diseases [C. H., E. F. S., P. E. P.], University Hospital Vrije Universiteit, 1081 HV Amsterdam, the Netherlands

Purpose: Here we report on the role of mitochondria, death receptors (DRs), and caspases in exerting the cytotoxic effect of clinically relevant concentrations of paclitaxel in the non-small cell lung cancer cell line NCI-H460.

Experimental Design: We have characterized paclitaxel-induced cell death with annexin V, propidium iodide staining, and poly(ADP-ribose) polymerase cleavage assays. The involvement of the mitochondria pathway was studied by monitoring cytochrome c release and using H460 cells stable in overexpressing Bcl-2 or Bcl-xL. DR dependency was analyzed in FADD dominant-negative or cytokine response modifier A-overexpressing cells, and a possible role for DR4 and DR5 was investigated by antagonistic antibodies. Caspase activity and cleavage assays and treatment with the synthetic inhibitor zVAD-fmk were used to determine the involvement of caspases.

Results: Paclitaxel-treated cells displayed several features of apoptosis, including annexin V staining and poly(ADP-ribose) polymerase cleavage. The sequence of events suggested the involvement of a DR, as indicated by an early role for Fas-associated death domain and caspase-8, followed by cleavage of Bid and the disruption of mitochondria; nonetheless, we failed to demonstrate the involvement of DR4 and DR5. Interestingly, inhibition of either one of these routes only resulted in a 30% reduction of cell death that was in line with the observed small effect of caspase inhibition by zVAD-fmk on H460 cell survival.

Conclusion: Paclitaxel triggers cell death in H460 cells mainly via a currently unidentified caspase-independent mechanism in which the basic apoptotic machinery is merely coactivated. This finding is in sharp contrast with the largely caspase-dependent response elicited by DNA-damaging agents in these cells. We speculate on therapeutic implications.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. S. Choe, Z. Chen, C. M. Klass, X. Zhang, and D. M. Shin
Enhancement of Docetaxel-Induced Cytotoxicity by Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways in Squamous Cell Carcinoma of the Head and Neck
Clin. Cancer Res., May 15, 2007; 13(10): 3015 - 3023.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Vijapurkar, W. Wang, and R. Herbst
Potentiation of Kinesin Spindle Protein Inhibitor-Induced Cell Death by Modulation of Mitochondrial and Death Receptor Apoptotic Pathways
Cancer Res., January 1, 2007; 67(1): 237 - 245.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. E. Broker, F. A.E. Kruyt, and G. Giaccone
Cell Death Independent of Caspases: A Review
Clin. Cancer Res., May 1, 2005; 11(9): 3155 - 3162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Park, C.-H. Wu, J. D. Gordon, X. Zhong, A. Emami, and A. R. Safa
Taxol Induces Caspase-10-dependent Apoptosis
J. Biol. Chem., December 3, 2004; 279(49): 51057 - 51067.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Zou, H. Fu, S. Ghosh, D. Farquhar, and J. Klostergaard
Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Models
Clin. Cancer Res., November 1, 2004; 10(21): 7382 - 7391.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. E. Broker, C. Huisman, S. W. Span, J. A. Rodriguez, F. A. E. Kruyt, and G. Giaccone
Cathepsin B Mediates Caspase-Independent Cell Death Induced by Microtubule Stabilizing Agents in Non-Small Cell Lung Cancer Cells
Cancer Res., January 1, 2004; 64(1): 27 - 30.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Waxman and P. S. Schwartz
Harnessing Apoptosis for Improved Anticancer Gene Therapy
Cancer Res., December 15, 2003; 63(24): 8563 - 8572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Masuda, K. Maeno, T. Nakagawa, H. Saito, and T. Takahashi
Association between Mitotic Spindle Checkpoint Impairment and Susceptibility to the Induction of Apoptosis by Anti-Microtubule Agents in Human Lung Cancers
Am. J. Pathol., September 1, 2003; 163(3): 1109 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Yang, T. Mashima, S. Sato, M. Mochizuki, H. Sakamoto, T. Yamori, T. Oh-hara, and T. Tsuruo
Predominant Suppression of Apoptosome by Inhibitor of Apoptosis Protein in Non-Small Cell Lung Cancer H460 Cells: Therapeutic Effect of a Novel Polyarginine-conjugated Smac Peptide
Cancer Res., February 15, 2003; 63(4): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. M. LaVallee, X. H. Zhan, M. S. Johnson, C. J. Herbstritt, G. Swartz, M. S. Williams, W. A. Hembrough, S. J. Green, and V. S. Pribluda
2-Methoxyestradiol Up-Regulates Death Receptor 5 and Induces Apoptosis through Activation of the Extrinsic Pathway
Cancer Res., January 15, 2003; 63(2): 468 - 475.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. E. Broker, C. Huisman, C. G. Ferreira, J. A. Rodriguez, F. A. E. Kruyt, and G. Giaccone
Late Activation of Apoptotic Pathways Plays a Negligible Role in Mediating the Cytotoxic Effects of Discodermolide and Epothilone B in Non-Small Cell Lung Cancer Cells
Cancer Res., July 15, 2002; 62(14): 4081 - 4088.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.